Adults living with ITP more commonly progress to the chronic form of Immune Thrombocytopenia, with more women with the disease in the 30 to 60year age group; however, it’s relatively equal across the other age groups.

There are many treatment options available in Australia and New Zealand for those living with ITP. Information regarding these treatments and FREE downloadable Information Sheets can be found by heading to the Support > Patient Resources page.

Haematologists refer to the
Consensus Guidelines for the Management of
Adult Immune Thrombocytopenia(ITP)
in Australia and New Zealand.

These guidelines were developed and published in 2021 and updated in 2023 to include additional therapies and changes to the access to some therapies in Australia.

Thank you to the authors and THANZ for supporting their work.

Download your copy by heading to the Support > Patient Resources page.

*Information based on data from the ITP Support Association, United Kingdom